Nanjing Vazyme Biotech Market Cap

Nanjing Vazyme Biotech has a market cap or net worth of 8.69 billion as of May 23, 2025. Its market cap has decreased by -13.20% in one year.

Market Cap

8.69B

Enterprise Value

6.87B

Revenue

1.36B

Ranking

n/a

PE Ratio

n/a

Stock Price

21.92

Market Cap Chart

Since November 15, 2021, Nanjing Vazyme Biotech's market cap has decreased from 34.14B to 8.69B, a decrease of -74.55%. That is a compound annual growth rate of -32.20%.

Market Cap History

Date	Market Cap	% Change
May 23, 2025	8.69B	-1.37%
Dec 31, 2024	8.81B	-31.21%
Dec 29, 2023	12.81B	-39.74%
Dec 30, 2022	21.26B	-49.87%
Dec 31, 2021	42.40B	24.19%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	369.18B
Shenzhen Mindray Bio-Medical Electronics	274.13B
WuXi AppTec	177.18B
Zhangzhou Pientzehuang Pharmaceutical.,	124.55B
Aier Eye Hospital Group	117.89B
Shanghai United Imaging Healthcare	112.34B
Sichuan Biokin Pharmaceutical	108.43B
Yunnan Baiyao Group Co.,Ltd	101.17B

Market Cap Rankings